UBS downgraded Ambev (ABEV) to Neutral from Buy with a R$16 price target Given the 20% year-to-date return, the analyst sees a more balanced risk/reward at current levels.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEV:
- Ambev S.A. Expands Shareholdings with Significant Purchases in March 2025
- Ambev S.A. Reports March 2025 Securities Transactions
- Ambev downgraded to Underweight from Equal Weight at Morgan Stanley
- Ambev price target raised to $2.45 from $2.20 at BofA
- Ambev S.A. Files April 2024 SEC Report Detailing Corporate and Securities Information
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue